| INTRODUCTION
Exome sequencing (ES) is a powerful tool for dissecting the genetic basis of Mendelian conditions, including both the identification of novel disease genes and the diagnosis of monogenic diseases (Chong, Buckingham et al., 2015) . ES has been particularly useful for making a precise molecular diagnosis of phenotypically and genetically heterogeneous disorders. In turn, this has broadened the spectrum of phenotypes of many known Mendelian conditions and the number of conditions associated to single genes (Dyment et al., 2015; Thevenon et al., 2016) .
Mutations in GLE1 have been reported to underlie two autosomal recessive conditions, Lethal Congenital Contracture Syndrome 1 (LCCS1; OMIM #253310) and Lethal Arthrogryposis with Anterior Horn Cell Disease (LAAHD; OMIM #611890), which result in death in the fetal and perinatal period, respectively (Nousiainen et al., 2008) . LCCS1 is characterized by a lack of fetal movements in the second trimester of pregnancy. Affected individuals typically present with intrauterine growth retardation (IUGR), fetal hydrops, micrognathia, pulmonary hypoplasia, and multiple joint contractures (Herva, Leisti, Kirkinen, & Seppanen, 1985) . Individuals with LAAHD present with a similar albeit "milder" phenotype, with prenatal onset of diminished fetal mobility and contractures, and post-natal respiratory failure resulting in perinatal death (Vuopala & Herva, 1994) .
Herein, we report the delineation of two unrelated individuals with a phenotype similar to LAAHD, who survived beyond 4 years of life, and were either homozygous or compound heterozygous for missense variants in GLE1. These findings expand the phenotype of LAAHD and suggest that either some mutations in GLE1 are associated with better outcomes and/or differences in intervention early in life can improve outcomes.
| CLINICAL FINDINGS
The study was approved by the Ethics Committee of the University Medical Center Hamburg-Eppendorf, Malta, and the Institutional Review Board of the University of Washington.
| Family A
Proband 1 (Figure 1 ; Supplementary Material, Table S1 ) was the firstborn male of healthy non-consanguineous parents of European and At the age of 12 months, he had a flexion contracture of the left hip, decreased abduction of both shoulders, and decreased extension of both elbows. He sat unsupported at 10 months and walked with a broad base gait at 3 years 8 months. Examination at 4 years 8 months of age revealed continued expressive speech delay due mainly to micrognathia but his receptive language was normal. His muscle bulk was markedly diminished. He could walk without assistance but occasionally used a K-walker.
| Family B
Proband 2 ( Figure 1 and Table S1 ) was the first-born female of healthy non-consanguineous parents of European ancestry. A previous pregnancy was terminated at 20 weeks because of generalized nonimmune hydrops fetalis, however, no genetic analysis was performed, and fetal DNA was not obtained. Proband 2 was born at 41 weeks gestational age via vacuum extraction due to fetal bradycardia. Her birth weight was 2,930 g (−1.4 SD), birth length 48 cm (−1.8 SD), and OFC 34.5 cm (−0.4 SD).
She was evaluated at 12 months of age because of suspected developmental delay. She sat unsupported at age of 12 months, crawled at 15 months, and stood at 15 months. At 2 years and 5 months, she could speak 10 words, but not a full sentence.
Examination at age of 3 years and 3 months ( Figure 1b ) revealed a restless girl with truncal hypotonia, dystonic movements of the upper limbs, involuntary facial grimacing and eye movements, and unmotivated yelling. She was unable to sit or walk unsupported, and protective reflexes were depressed. Supported gait was ataxic. Her weight, height, and OFC were within the normal range.
Starting at the age of 14 months, she developed frequent febrile infections that each resulted in loss of motor skills and extended recovery time. At the age 3 years 8 months, she had parainfluenza pneumonia which progressed to severe hypoxemic respiratory failure requiring ventilation. After prolonged weaning from the ventilator, she developed delirium and motor abnormalities with flailing of arms and legs, grimacing, and writing movements, even while asleep. These involuntary movements improved over the next weeks but she had lost her gross motor skills including sitting and crawling. Repeated MRI of brain showed generalized parenchymal volume loss and a small brainstem. After her fourth bout of pneumonia she died of respiratory insufficiency at the age of 4 years.
| GENETIC RESULTS
ES and analysis were performed as described in families A (Chong, Mcmillin et al., 2015) and B (Hempel et al., 2015) . A Table S1 ).
Taken together, both the genetic and phenotypic data suggest that the GLE1 variants identified (Figure 2 and Supplementary Material, Table S1 ) are causal for a phenotype overlapping LAAHD and LCCS1. Investigators studying the two affected individuals described here connected via GeneMatcher (Sobreira, Schiettecatte, Valle, & Hamosh, 2015) , a member of MatchMaker Exchange (MME) (Philippakis et al., 2015) . Table S2 ). Indeed, no fetus with LCCS1 surviving beyond 35 weeks EGA or infant with LAADH surviving beyond 8 weeks after birth has been reported until the recent publication of single exception (Smith et al., 2017) . Accordingly, the natural history of the children reported herein is considerably different from that of children with either LCCS1 or LAADH (Supplementary Material, Table S2 ). This observation suggests that either the children reported herein have a condition distinct from both LCCS1 and LAADH, that mutations in GLE1 produce a single condition with a broad distribution of phenotypes, or that these children represent phenotypic expansion of LCCS1 or LAAHD. Smith et al. (2017) recently reported a family with two affected brothers, one of whom died at 2 weeks of age while the other survived to 12 years, who were compound heterozygotes for GLE1 variants, c.100-7_100-3delTCTCT (p. [D34_K107del] ) and c.1882-2A>G (p.[V238_Nfs*2]). Smith et al. (2017) proposed that LCCS1 and LAAHD constitute the same clinical entity with variable severity because the two disorders have "nearly indistinguishable phenotypes." However, the observation that all individuals homozygous for p.T144_E145insPFQ died prenatally and exhibit no fetal movements during gestation (Supplementary Material, Table S2) suggests that LCCS1 represents a distinct clinical entity as the prognosis is different than for individuals who have biallelic GLE1 mutations. This is similar to other human genes in which a specific or small number of mutations result in a distinct phenotype (e.g., FGFR3 and achondroplasia).
GLE1 is an essential mRNA export factor (Watkins, Murphy, Emtage, & Wente, 1998 ) that also plays a role in both initiation and termination of protein translation in eukaryotes (Bolger, Folkmann, Tran, & Wente, 2008; Folkmann, Collier, Zhan, & Ohi, 2013) . GLE1 encodes at least two nearly identical isoforms, GLE1A and GLE1B. | 3101 C-terminal 43 amino acid segment unique to GLE1B (Figure 2b ) is required for localization of GLE1 to the NPC (Kendirgi et al., 2003 (Kendirgi et al., , 2005 . Nevertheless, this difference leads to distinct functions: GLE1B exports mRNAs from the nucleus to the cytoplasm via the NPC, while GLE1A localizes to the cytoplasm and is required for stress granule assembly and disassembly, thereby regulating protein translation (Aditi, Folkmann & Wente, 2015) .
Each of the variants we identified affects a residue(s) located in the C terminus of GLE1 (Figure 2 and Supplementary Material, Table S1 ), suggesting a possible relationship between affected domain(s) or affected isoform(s) and phenotype. However, other than proband A, who is homozygous for p.(S693F), a variant that lies in the domain unique to GLE1B, all individuals with GLE1 mutations reported to date have either one or two mutations predicted to affect both isoforms (Supplementary Material, Table S1 ). Therefore, we cannot readily distinguish any relationships between observed phenotype features, severity, and type or location of a variant.
We predict that biallelic mutations that truncate or otherwise result in loss of function of the coiled-coil domain of both GLE1 isoforms cause LCCS1. In contrast, individuals with mutations that preserve the function of the coiled-coil domain in both isoforms cause LAAHD. We also suggest that because the phenotype of LAAHD is now expanded to include multiple individuals surviving into childhood, LAAHD should be re-named Arthrogryposis with Anterior Horn Cell Disease (AAHD).
